Related references
Note: Only part of the references are listed.The development of RAPTA compounds for the treatment of tumors
Benjamin S. Murray et al.
COORDINATION CHEMISTRY REVIEWS (2016)
Protein ruthenation and DNA alkylation: chlorambucil-functionalized RAPTA complexes and their anticancer activity
Alexey A. Nazarov et al.
DALTON TRANSACTIONS (2015)
Increasing the selectivity of biologically active tetranuclear arene ruthenium assemblies
Gajendra Gupta et al.
JOURNAL OF ORGANOMETALLIC CHEMISTRY (2015)
Cytotoxic peptide conjugates of dinuclear arene ruthenium trithiolato complexes
Federico Giannini et al.
MEDCHEMCOMM (2015)
Opening the lid on piano-stool complexes: An account of ruthenium(II)-arene complexes with medicinal applications
Alexey A. Nazarov et al.
JOURNAL OF ORGANOMETALLIC CHEMISTRY (2014)
Identification of the Structural Determinants for Anticancer Activity of a Ruthenium Arene Peptide Conjugate
Samuel M. Meier et al.
CHEMISTRY-A EUROPEAN JOURNAL (2013)
Next-Generation Metal Anticancer Complexes: Multitargeting via Redox Modulation
Isolda Romero-Canelon et al.
INORGANIC CHEMISTRY (2013)
Synthesis, characterization and in vitro anticancer activity of highly cytotoxic trithiolato diruthenium complexes of the type [(η6-p-MeC6H4iPr)2Ru2(μ2-SR1)2(μ2-SR2)]+ containing different thiolato bridges
Federico Giannini et al.
JOURNAL OF ORGANOMETALLIC CHEMISTRY (2013)
Highly cytotoxic diruthenium trithiolato complexes of the type [(eta(6)-p-MeC6H4Pri)(2)Ru-2(mu(2)-SR)(3)](+): synthesis, characterization, molecular structure and in vitro anticancer activity
Federico Giannini et al.
NEW JOURNAL OF CHEMISTRY (2013)
Tumor angiogenesis is enforced by autocrine regulation of high-mobility group box 1
J. R. van Beijnum et al.
ONCOGENE (2013)
Thiolato-Bridged Arene-Ruthenium Complexes: Synthesis, Molecular Structure, Reactivity, and Anticancer Activity of the Dinuclear Complexes [(arene)2Ru2(SR)2Cl2]
Anne-Flore Ibao et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2012)
Highly cytotoxic trithiophenolatodiruthenium complexes of the type [(η6-p-MeC6H4Pr i )2Ru2(SC6H4-p-X)3]+: synthesis, molecular structure, electrochemistry, cytotoxicity, and glutathione oxidation potential
Federico Giannini et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2012)
Thermoresponsive Chlorambucil Derivatives for Tumour Targeting
Catherine M. Clavel et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
Chlorambucil—Still Not Bad: A Reappraisal
Daniel Catovsky et al.
Clinical Lymphoma Myeloma & Leukemia (2011)
Targeted and multifunctional arene ruthenium chemotherapeutics
Gregory S. Smith et al.
DALTON TRANSACTIONS (2011)
Efficient Oxidation of Cysteine and Glutathione Catalyzed by a Dinuclear Areneruthenium Trithiolato Anticancer Complex
Federico Giannini et al.
INORGANIC CHEMISTRY (2011)
Thiophenolato-bridged dinuclear arene ruthenium complexes: a new family of highly cytotoxic anticancer agents
Michael Gras et al.
DALTON TRANSACTIONS (2010)
Arene ruthenium complexes as anticancer agents
Georg Suess-Fink
DALTON TRANSACTIONS (2010)
In vivo tumour and metastasis reduction and in vitro effects on invasion assays of the ruthenium RM175 and osmium AFAP51 organometallics in the mammary cancer model
A. Bergamo et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2010)
Chlorambucil-Adducts in DNA Analyzed at the Oligonucleotide Level Using HPLC-ESI MS
Dalia Mohamed et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2009)
A categorization of metal anticancer compounds based on their mode of action
Teresa Gianferrara et al.
DALTON TRANSACTIONS (2009)
New trends for metal complexes with anticancer activity
Pieter C. A. Bruijnincx et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2008)
Metal based drugs: from serendipity to design
Simon Paul Fricker
DALTON TRANSACTIONS (2007)
Non platinum metal complexes as anti-cancer drugs
Ingo Ott et al.
ARCHIV DER PHARMAZIE (2007)
Ruthenium complexes as anticancer agents
I Kostova
CURRENT MEDICINAL CHEMISTRY (2006)
In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes
C Scolaro et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.
KR Rai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
